News

Home > News

15 Jul, 2026

MHSRS 2026

We’re heading to MHSRS 2026! Rafa Laboratories is pleased to announce our participation in the Military Health System Research Symposium...

22 Jun, 2026

Rafa Laboratories Secures Landmark $46 Million Atropine Supply Deal with ASPR, Solidifying Global Leadership in Medical Countermeasures

Jerusalem, Israel – 22.6.2026 – Rafa Laboratories , a global leader in the development, manufacture and supply of medical countermeasures, announces...

19 Nov, 2025

Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving Intramuscular TXA Injection for Prehospital Care

JERUSALEM, Nov. 19, 2025 /PRNewswire/ — Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense,...

29 Jul, 2025

MHSRS 2025

We’re heading to MHSRS 2025! We are excited to announce that Rafa Laboratories will be participating in the Military Health...

10 Nov, 2024

Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to Advance the Development of a new design for Rafa’s Pediatric Atropine Autoinjectors

JERUSALEM, March 20, 2024 /CNW/ — Rafa Laboratories, LTD., a leading manufacturer of Emergency Medical Solutions, and the Biomedical Advanced Research and...

The information on this website is intended only for
professionals in the pharmaceutical and CBRN fields.

Are you a specialist in one of these areas?